| |
Overall
|
FMT
|
Placebo
|
P value
|
|---|
|
N
|
55
|
28
|
27
| |
|
Age (mean ± SD)
|
40.3 ± 6.3
|
40.9 ± 7.4
|
39.7 ± 5.2
|
0.685
|
|
Weight (mean ± SD)
|
60.1 ± 3.9
|
59.2 ± 3.8
|
61.0 ± 4.0
|
0.833
|
|
Height (mean ± SD)
|
1.67 ± 0.07
|
1.69 ± 0.04
|
1.65 ± 3.98
|
0.734
|
|
BMI (mean ± SD)
|
21.7 ± 2.0
|
20.8 ± 1.6
|
22.5 ± 2.4
|
0.906
|
|
Male (%)
|
20(36.4)
|
10(35.7)
|
10(37.0)
|
0.906
|
|
Continue use of SIBO medication (%)
|
33(60.0)
|
17(60.7)
|
16(59.3)
|
0.579
|
|
Former tried SIBO medication (%)
|
42(76.4)
|
23(82.1)
|
19(70.4)
|
0.382
|
|
Former tried FODMAP diet (%)
|
26(47.3)
|
12(42.9)
|
14(51.9)
|
0.652
|
|
Born by casarean section (%)
|
7(12.7)
|
3(10.7)
|
4(14.8)
|
1
|
|
PPI (%)
|
9(16.4)
|
3(10.7)
|
6(22.2)
|
0.974
|
|
Antacid (%)
|
8(14.5)
|
4(14.3)
|
4(14.8)
|
0.523
|
|
Bile acid inhibitor (%)
|
5(9.1)
|
4(14.3)
|
1(3.7)
|
1
|
|
Immunosuppressor (%)
|
2(3.6)
|
1(3.6)
|
1(3.7)
|
1
|
- BMI, body mass index; SIBO, small intestinal bacterial overgrowth; PPI, proton pump inhibitor
